• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus.尼可霉素Z与棘白菌素FK463联合作用于烟曲霉的协同作用、药效学及时间序列超微结构变化
Antimicrob Agents Chemother. 2001 Dec;45(12):3310-21. doi: 10.1128/AAC.45.12.3310-3321.2001.
2
In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus.尼可霉素Z单独及与多烯类、三唑类或棘白菌素类联合对烟曲霉的体外活性。
Clin Microbiol Infect. 2004 Nov;10(11):961-6. doi: 10.1111/j.1469-0691.2004.00996.x.
3
Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatus.新型棘白菌素米卡芬净与人类吞噬细胞联合作用对烟曲霉的抗真菌活性
Microbes Infect. 2004 Apr;6(4):383-9. doi: 10.1016/j.micinf.2003.12.010.
4
Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.卡泊芬净对曲霉属真菌代谢活性的浓度依赖性效应。
Antimicrob Agents Chemother. 2007 Mar;51(3):881-7. doi: 10.1128/AAC.01160-06. Epub 2006 Dec 4.
5
In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.卡泊芬净联合磺胺甲恶唑对曲霉属临床分离株的体外活性
Antimicrob Agents Chemother. 2004 Sep;48(9):3279-83. doi: 10.1128/AAC.48.9.3279-3283.2004.
6
Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.伏立康唑联合米卡芬净对念珠菌、曲霉菌、赛多孢属菌及茄病镰刀菌的作用。
Antimicrob Agents Chemother. 2005 Dec;49(12):5157-9. doi: 10.1128/AAC.49.12.5157-5159.2005.
7
In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi.新型脂肽抗真菌剂FK463对多种临床重要真菌的体外活性
Antimicrob Agents Chemother. 2000 Jan;44(1):57-62. doi: 10.1128/AAC.44.1.57-62.2000.
8
In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.新型脂肽抗真菌剂FK463对多种真菌病原体的体外抗真菌活性。
J Antibiot (Tokyo). 2000 Oct;53(10):1175-81. doi: 10.7164/antibiotics.53.1175.
9
Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (Nikkomycin Z) for inhibition and killing of fungal pathogens.一种葡聚糖合酶抑制剂(LY 303366)和一种几丁质合酶抑制剂(多氧霉素Z)对真菌病原体抑制和杀灭作用的药物相互作用研究。
Antimicrob Agents Chemother. 2000 Sep;44(9):2547-8. doi: 10.1128/AAC.44.9.2547-2548.2000.
10
Effects of micafungin on the morphology of Aspergillus fumigatus.米卡芬净对烟曲霉形态的影响。
J Electron Microsc (Tokyo). 2005 Jan;54(1):67-77. doi: 10.1093/jmicro/dfh100.

引用本文的文献

1
Ultrastructural and Immunohistochemical Study of Double and Combined Intravitreal Administration of Antifungal Agents in the Retina of New Zealand Albino Rabbits: An Experimental Protocol.新西兰白化兔视网膜玻璃体内联合及复合应用抗真菌药物的超微结构和免疫组织化学研究:一项实验方案
J Fungi (Basel). 2025 Jul 29;11(8):564. doi: 10.3390/jof11080564.
2
Synergistic Antifungal Activity of Pentamidine and Auranofin Against Multidrug-Resistant Candida auris.喷他脒和金诺芬对多重耐药耳念珠菌的协同抗真菌活性
Mycopathologia. 2025 May 14;190(3):41. doi: 10.1007/s11046-025-00948-4.
3
Alexidine as a Potent Antifungal Agent Against .洗必泰作为一种针对……的强效抗真菌剂。 (原文不完整,翻译可能不太准确,完整准确翻译需补充完整原文内容)
ACS Omega. 2025 Mar 20;10(12):12366-12374. doi: 10.1021/acsomega.4c11382. eCollection 2025 Apr 1.
4
New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions.侵袭性真菌感染的抗真菌发现与治疗新领域:创新、挑战与未来方向
J Fungi (Basel). 2024 Dec 15;10(12):871. doi: 10.3390/jof10120871.
5
Molecular and ultrastructural morphological analyses of highly metamorphosed Aspergillus fumigatus on human formalin-fixed paraffin-embedded tissue.人甲醛固定石蜡包埋组织中高度变异烟曲霉的分子和超微结构形态分析。
Med Mol Morphol. 2024 Dec;57(4):326-332. doi: 10.1007/s00795-024-00402-2. Epub 2024 Aug 14.
6
Topical Nanoemulsions as Delivery Systems for Green Extracts of Aiming at the Treatment of Sporotrichosis.作为用于旨在治疗孢子丝菌病的绿色提取物递送系统的局部纳米乳剂
Pharmaceutics. 2024 Apr 2;16(4):492. doi: 10.3390/pharmaceutics16040492.
7
Non- Hyaline Molds: A Host-Based Perspective of Emerging Pathogenic Fungi Causing Sinopulmonary Diseases.非透明霉菌:从宿主角度看引起鼻窦肺部疾病的新兴致病真菌
J Fungi (Basel). 2023 Feb 6;9(2):212. doi: 10.3390/jof9020212.
8
Sources of Antifungal Drugs.抗真菌药物的来源
J Fungi (Basel). 2023 Jan 28;9(2):171. doi: 10.3390/jof9020171.
9
Chitin Biosynthesis in Species.物种中的几丁质生物合成
J Fungi (Basel). 2023 Jan 6;9(1):89. doi: 10.3390/jof9010089.
10
Antimicrobial Peptides: a New Frontier in Antifungal Therapy.抗菌肽:抗真菌治疗的新前沿。
mBio. 2020 Nov 3;11(6):e02123-20. doi: 10.1128/mBio.02123-20.

本文引用的文献

1
Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (Nikkomycin Z) for inhibition and killing of fungal pathogens.一种葡聚糖合酶抑制剂(LY 303366)和一种几丁质合酶抑制剂(多氧霉素Z)对真菌病原体抑制和杀灭作用的药物相互作用研究。
Antimicrob Agents Chemother. 2000 Sep;44(9):2547-8. doi: 10.1128/AAC.44.9.2547-2548.2000.
2
Characterization of the chitin biosynthesis process as a compensatory mechanism in the fks1 mutant of Saccharomyces cerevisiae.将几丁质生物合成过程表征为酿酒酵母fks1突变体中的一种补偿机制。
FEBS Lett. 2000 Jul 28;478(1-2):84-8. doi: 10.1016/s0014-5793(00)01835-4.
3
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.治疗癌症患者侵袭性真菌感染的新药和新靶点
Oncologist. 2000;5(2):120-35. doi: 10.1634/theoncologist.5-2-120.
4
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis.新型脂肽类抗真菌药物FK463在小鼠肺曲霉病模型中的疗效
Antimicrob Agents Chemother. 2000 Mar;44(3):619-21. doi: 10.1128/AAC.44.3.619-621.2000.
5
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis.新型脂肽抗真菌剂FK463在播散性念珠菌病和曲霉病小鼠模型中的疗效。
Antimicrob Agents Chemother. 2000 Mar;44(3):614-8. doi: 10.1128/AAC.44.3.614-618.2000.
6
In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi.新型脂肽抗真菌剂FK463对多种临床重要真菌的体外活性
Antimicrob Agents Chemother. 2000 Jan;44(1):57-62. doi: 10.1128/AAC.44.1.57-62.2000.
7
Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development.全身性抗真菌药物的临床药理学:对临床使用药物、当前研究中的化合物以及抗真菌药物开发的假定靶点的全面综述。
Adv Pharmacol. 1998;44:343-500. doi: 10.1016/s1054-3589(08)60129-5.
8
Kinetics of nikkomycin Z degradation in aqueous solution and in plasma.尼可霉素Z在水溶液和血浆中的降解动力学。
Biol Pharm Bull. 1997 May;20(5):577-80. doi: 10.1248/bpb.20.577.
9
Therapeutic outcome in invasive aspergillosis.侵袭性曲霉病的治疗结果
Clin Infect Dis. 1996 Sep;23(3):608-15. doi: 10.1093/clinids/23.3.608.
10
Compounds active against cell walls of medically important fungi.对医学上重要真菌的细胞壁具有活性的化合物。
Clin Microbiol Rev. 1993 Jan;6(1):1-21. doi: 10.1128/CMR.6.1.1.

尼可霉素Z与棘白菌素FK463联合作用于烟曲霉的协同作用、药效学及时间序列超微结构变化

Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus.

作者信息

Chiou C C, Mavrogiorgos N, Tillem E, Hector R, Walsh T J

机构信息

Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.

出版信息

Antimicrob Agents Chemother. 2001 Dec;45(12):3310-21. doi: 10.1128/AAC.45.12.3310-3321.2001.

DOI:10.1128/AAC.45.12.3310-3321.2001
PMID:11709302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC90831/
Abstract

We investigated the potential synergy between two cell wall-active agents, the echinocandin FK463 (FK) and the chitin synthase inhibitor nikkomycin Z (NZ), against 16 isolates of filamentous fungi. Susceptibility testing was performed with a broth macrodilution procedure by NCCLS methods. The median minimal effective concentration (MEC) of FK against all Aspergillus species was 0.25 microg/ml (range, 0.05 to 0.5 microg/ml). For Fusarium solani and Rhizopus oryzae, MECs of FK were >512 microg/ml. The median MEC of NZ against Aspergillus fumigatus was 32 microg/ml (range, 8 to 64 microg/ml), and that against R. oryzae was 0.5 microg/ml (range, 0.06 to 2 microg/ml); however, for the other Aspergillus species, as well as F. solani, MECs were >512 microg/ml. A checkerboard inhibitory assay demonstrated synergy against A. fumigatus (median fractional inhibitory concentration index = 0.312 [range, 0.15 to 0.475]). The effect was additive to indifferent against R. oryzae and indifferent against other Aspergillus spp. and F. solani. We further investigated the pharmacodynamics of hyphal damage by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay and examined the time-sequenced changes in hyphal ultrastructure. Significant synergistic hyphal damage was demonstrated with the combination of NZ (2 to 32 microg/ml) and FK (0.03 to 0.5 microg/ml) over a wide range of concentrations (P < 0.001). The synergistic effect was most pronounced after 12 h of incubation and was sustained through 24 h. Time-sequenced light and electron microscopic studies demonstrated that structural alterations of hyphae were profound, with marked transformation of hyphae to blastospore-like structures, in the presence of FK plus NZ, while fungi treated with a single drug showed partial recovery at 24 h. The methods used in this study may be applicable to elucidating the activity and interaction of other cell wall-active agents. In summary, these two cell wall-targeted antifungal agents, FK and NZ, showed marked time-dependent in vitro synergistic activity against A. fumigatus.

摘要

我们研究了两种细胞壁活性药物棘白菌素FK463(FK)和几丁质合成酶抑制剂多氧霉素Z(NZ)对16株丝状真菌的潜在协同作用。采用美国国家临床实验室标准化委员会(NCCLS)方法通过肉汤稀释法进行药敏试验。FK对所有曲霉菌种的中位最小有效浓度(MEC)为0.25微克/毫升(范围为0.05至0.5微克/毫升)。对于茄病镰刀菌和米根霉,FK的MEC>512微克/毫升。NZ对烟曲霉的中位MEC为32微克/毫升(范围为8至64微克/毫升),对米根霉的中位MEC为0.5微克/毫升(范围为0.06至2微克/毫升);然而,对于其他曲霉菌种以及茄病镰刀菌,MEC>512微克/毫升。棋盘抑制试验证明对烟曲霉有协同作用(中位分数抑制浓度指数=0.312[范围为0.15至0.475])。对米根霉的作用为相加至无作用,对其他曲霉菌种和茄病镰刀菌为无作用。我们通过MTT[3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐]试验进一步研究了菌丝损伤的药效学,并检查了菌丝超微结构的时间序列变化。在很宽的浓度范围内(P<0.001),NZ(2至32微克/毫升)和FK(0.03至0.5微克/毫升)联合使用显示出显著的协同菌丝损伤。协同作用在孵育12小时后最为明显,并持续至24小时。时间序列的光学和电子显微镜研究表明,在FK加NZ存在的情况下,菌丝的结构改变很显著,菌丝明显转变为芽生孢子样结构,而用单一药物处理的真菌在24小时时显示部分恢复。本研究中使用的方法可能适用于阐明其他细胞壁活性药物的活性和相互作用。总之,这两种针对细胞壁的抗真菌药物FK和NZ在体外对烟曲霉显示出显著的时间依赖性协同活性。